Lineage Cell Therapeutics Inc (NYSE American:LCTX)

1.40
BATS BZX Real-Time Price
As of 1:58pm ET
 -0.01 / -0.71%
Today’s Change
1.02
Today|||52-Week Range
2.71
-42.86%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Lineage Cell Therapeutics Inc have a median target of 5.50, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +292.86% increase from the last price of 1.40.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Lineage Cell Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.04
Sales
$2.6M
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.14%
 
 
 
 
 
 
Growthannually 41.21%
 
 
 
 
 
 

Sales

Growthquarterly -14.43%
 
 
 
 
 
 
Growthannually 253.71%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.